STAR
Basic information
Region (hg38): 8:38142700-38150992
Links
Phenotypes
GenCC
Source:
- congenital lipoid adrenal hyperplasia due to STAR deficency (Definitive), mode of inheritance: AR
- congenital lipoid adrenal hyperplasia due to STAR deficency (Definitive), mode of inheritance: AR
- congenital lipoid adrenal hyperplasia due to STAR deficency (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Lipoid adrenal hyperplasia | AR | Endocrine; Genitourinary; Oncologic | Due to the severity of disease, most individuals present as phenotypic females with fatal salt-wasting adrenal crises if untreated in early infancy (patients may also present later in life with milder forms of disease), and medical treatment (eg, with glucocorticoid and mineralcorticoid replacement) may be beneficial; Treatment of genitourinary anomalies (eg, with surgery, including related to the risk of malignancy in genotypic males) may be indicated in some individuals | Endocrine; Genitourinary; Oncologic | 13968788; 4685387; 3841304; 2419119; 1661294; 7892608; 7547998; 8948562; 9077535; 10323391; 11061515; 16968793; 21057961; 21691971; 21714456; 21846663; 22028173; 22083155; 22249004 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (38 variants)
- Congenital lipoid adrenal hyperplasia due to STAR deficency (8 variants)
- STAR-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the STAR gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 113 | 114 | ||||
missense | 11 | 28 | 44 | |||
nonsense | 12 | 15 | ||||
start loss | 0 | |||||
frameshift | 19 | 20 | 39 | |||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 14 | 19 | ||||
splice region | 22 | 22 | ||||
non coding | 33 | 52 | 10 | 95 | ||
Total | 38 | 48 | 62 | 167 | 12 |
Highest pathogenic variant AF is 0.0000263
Variants in STAR
This is a list of pathogenic ClinVar variants found in the STAR region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-38142716-T-C | Congenital lipoid adrenal hyperplasia due to STAR deficency | Uncertain significance (Jan 12, 2018) | ||
8-38142730-G-T | Congenital lipoid adrenal hyperplasia due to STAR deficency | Uncertain significance (Jan 13, 2018) | ||
8-38142749-T-C | Congenital lipoid adrenal hyperplasia due to STAR deficency | Benign (Jan 12, 2018) | ||
8-38142760-G-C | Congenital lipoid adrenal hyperplasia due to STAR deficency | Uncertain significance (Jan 12, 2018) | ||
8-38142800-C-T | Congenital lipoid adrenal hyperplasia due to STAR deficency | Uncertain significance (Jan 12, 2018) | ||
8-38142801-G-A | Congenital lipoid adrenal hyperplasia due to STAR deficency | Uncertain significance (Jan 13, 2018) | ||
8-38142888-GA-G | Congenital adrenal hyperplasia | Uncertain significance (Jun 14, 2016) | ||
8-38143151-A-T | Congenital lipoid adrenal hyperplasia due to STAR deficency | Uncertain significance (Jan 12, 2018) | ||
8-38143286-T-C | Congenital lipoid adrenal hyperplasia due to STAR deficency | Benign (Jan 13, 2018) | ||
8-38143292-T-C | Congenital lipoid adrenal hyperplasia due to STAR deficency | Uncertain significance (Jan 13, 2018) | ||
8-38143305-AT-A | Congenital adrenal hyperplasia | Benign (Jun 14, 2016) | ||
8-38143305-A-ATTT | Congenital adrenal hyperplasia | Uncertain significance (Jun 14, 2016) | ||
8-38143324-TG-T | Congenital adrenal hyperplasia | Uncertain significance (Jun 14, 2016) | ||
8-38143343-G-A | Congenital lipoid adrenal hyperplasia due to STAR deficency | Uncertain significance (Jan 12, 2018) | ||
8-38143360-G-A | Congenital lipoid adrenal hyperplasia due to STAR deficency | Uncertain significance (Jan 13, 2018) | ||
8-38143376-G-A | Congenital lipoid adrenal hyperplasia due to STAR deficency | Uncertain significance (Jan 13, 2018) | ||
8-38143393-G-A | Congenital lipoid adrenal hyperplasia due to STAR deficency | Uncertain significance (Jan 13, 2018) | ||
8-38143455-C-T | Congenital lipoid adrenal hyperplasia due to STAR deficency | Uncertain significance (Jan 13, 2018) | ||
8-38143456-G-A | Congenital lipoid adrenal hyperplasia due to STAR deficency | Uncertain significance (Jan 13, 2018) | ||
8-38143477-T-C | Congenital lipoid adrenal hyperplasia due to STAR deficency | Uncertain significance (Jan 13, 2018) | ||
8-38143505-C-T | Congenital lipoid adrenal hyperplasia due to STAR deficency | Uncertain significance (Jan 13, 2018) | ||
8-38143574-G-C | Congenital lipoid adrenal hyperplasia due to STAR deficency | Uncertain significance (Jan 13, 2018) | ||
8-38143575-G-T | Congenital lipoid adrenal hyperplasia due to STAR deficency | Uncertain significance (Jan 13, 2018) | ||
8-38143585-G-A | Congenital lipoid adrenal hyperplasia due to STAR deficency | Uncertain significance (Jan 13, 2018) | ||
8-38143717-T-C | Congenital lipoid adrenal hyperplasia due to STAR deficency | Uncertain significance (Jan 13, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
STAR | protein_coding | protein_coding | ENST00000276449 | 7 | 7617 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.77e-11 | 0.0429 | 125682 | 0 | 66 | 125748 | 0.000262 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0892 | 172 | 169 | 1.02 | 0.0000109 | 1867 |
Missense in Polyphen | 29 | 32.947 | 0.88021 | 376 | ||
Synonymous | -1.01 | 73 | 62.8 | 1.16 | 0.00000387 | 547 |
Loss of Function | -0.198 | 15 | 14.2 | 1.06 | 7.09e-7 | 154 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000767 | 0.000767 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00118 | 0.00114 |
Finnish | 0.000185 | 0.000185 |
European (Non-Finnish) | 0.000115 | 0.000114 |
Middle Eastern | 0.00118 | 0.00114 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000817 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a key role in steroid hormone synthesis by enhancing the metabolism of cholesterol into pregnenolone. Mediates the transfer of cholesterol from the outer mitochondrial membrane to the inner mitochondrial membrane where it is cleaved to pregnenolone.;
- Pathway
- Cortisol synthesis and secretion - Homo sapiens (human);Aldosterone synthesis and secretion - Homo sapiens (human);Cushing,s syndrome - Homo sapiens (human);Cholesterol metabolism - Homo sapiens (human);Ovarian steroidogenesis - Homo sapiens (human);Corticotropin-releasing hormone signaling pathway;Metabolism of lipids;Metabolism;Pregnenolone biosynthesis;Metabolism of steroid hormones;Metabolism of steroids;Steroid hormones
(Consensus)
Recessive Scores
- pRec
- 0.430
Intolerance Scores
- loftool
- 0.351
- rvis_EVS
- -0.12
- rvis_percentile_EVS
- 45.13
Haploinsufficiency Scores
- pHI
- 0.243
- hipred
- N
- hipred_score
- 0.251
- ghis
- 0.416
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.867
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Star
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- steroid biosynthetic process;bile acid biosynthetic process;C21-steroid hormone biosynthetic process;estrogen biosynthetic process;brain development;response to nutrient;cholesterol metabolic process;glucocorticoid metabolic process;male gonad development;response to herbicide;response to ionizing radiation;response to lead ion;positive regulation of gene expression;response to activity;diterpenoid metabolic process;insecticide metabolic process;biphenyl metabolic process;dibenzo-p-dioxin metabolic process;phenol-containing compound metabolic process;phthalate metabolic process;intracellular cholesterol transport;cellular response to insulin stimulus;response to nicotine;cellular response to interferon-alpha;response to hydrogen peroxide;circadian sleep/wake cycle, REM sleep;negative regulation of neuron apoptotic process;response to estrogen;response to leptin;cellular response to fibroblast growth factor stimulus;response to ethanol;regulation of neuronal synaptic plasticity;positive regulation of neurogenesis;regulation of steroid biosynthetic process;response to corticosterone;response to fungicide;testosterone biosynthetic process;positive regulation of bile acid biosynthetic process;cellular response to lipopolysaccharide;cellular response to antibiotic;cellular response to cadmium ion;cellular response to alkaloid;cellular response to cAMP;cellular response to glucose stimulus;cellular response to interferon-gamma;cellular response to follicle-stimulating hormone stimulus;cellular response to luteinizing hormone stimulus;cellular response to growth hormone stimulus;cellular response to dexamethasone stimulus;cellular response to transforming growth factor beta stimulus;cellular response to epinephrine stimulus
- Cellular component
- mitochondrion;mitochondrial intermembrane space;cytosol;mitochondrial crista;neuron projection;neuronal cell body
- Molecular function
- protein binding;cholesterol binding;cholesterol transporter activity